Global Opthalmic Therapeutic Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 3624

Ophthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms at early stages. They will be painless with no defect in vision until the disease progresses to an advanced stage. Regular eye checkups must be done to detect the development of any disorder. Proper care and hygiene must be ensured to protect the eyes.
In 2018, the global Opthalmic Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Opthalmic Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Opthalmic Therapeutic development in United States, Europe and China.

The key players covered in this study
Pfizer
Novartis
GlaxoSmithKline
Alcon
Merck
Roche
Bayer
Actavis
Boehringer Ingelheim
R-Tech Ueno
Valeant Pharmaceuticals
Regeneron Pharmaceuticals
Acadia Pharmaceuticals
Allergan
Falcon Pharmaceuticals
Otsuka Pharmaceutical
Senju Pharmaceutical
OPKO Health
Lexicon Pharmaceuticals

Market segment by Type, the product can be split into
Oral
Injection
External Application

Market segment by Application, split into
Hospitals
Clinics
Home Care Settings
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Opthalmic Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Opthalmic Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Opthalmic Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Opthalmic Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Injection
1.4.4 External Application
1.5 Market by Application
1.5.1 Global Opthalmic Therapeutic Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home Care Settings
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Opthalmic Therapeutic Market Size
2.2 Opthalmic Therapeutic Growth Trends by Regions
2.2.1 Opthalmic Therapeutic Market Size by Regions (2014-2025)
2.2.2 Opthalmic Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Opthalmic Therapeutic Market Size by Manufacturers
3.1.1 Global Opthalmic Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global Opthalmic Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Opthalmic Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 Opthalmic Therapeutic Key Players Head office and Area Served
3.3 Key Players Opthalmic Therapeutic Product/Solution/Service
3.4 Date of Enter into Opthalmic Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Opthalmic Therapeutic Market Size by Type (2014-2019)
4.2 Global Opthalmic Therapeutic Market Size by Application (2014-2019)

5 United States
5.1 United States Opthalmic Therapeutic Market Size (2014-2019)
5.2 Opthalmic Therapeutic Key Players in United States
5.3 United States Opthalmic Therapeutic Market Size by Type
5.4 United States Opthalmic Therapeutic Market Size by Application

6 Europe
6.1 Europe Opthalmic Therapeutic Market Size (2014-2019)
6.2 Opthalmic Therapeutic Key Players in Europe
6.3 Europe Opthalmic Therapeutic Market Size by Type
6.4 Europe Opthalmic Therapeutic Market Size by Application

7 China
7.1 China Opthalmic Therapeutic Market Size (2014-2019)
7.2 Opthalmic Therapeutic Key Players in China
7.3 China Opthalmic Therapeutic Market Size by Type
7.4 China Opthalmic Therapeutic Market Size by Application

8 Japan
8.1 Japan Opthalmic Therapeutic Market Size (2014-2019)
8.2 Opthalmic Therapeutic Key Players in Japan
8.3 Japan Opthalmic Therapeutic Market Size by Type
8.4 Japan Opthalmic Therapeutic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Opthalmic Therapeutic Market Size (2014-2019)
9.2 Opthalmic Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia Opthalmic Therapeutic Market Size by Type
9.4 Southeast Asia Opthalmic Therapeutic Market Size by Application

10 India
10.1 India Opthalmic Therapeutic Market Size (2014-2019)
10.2 Opthalmic Therapeutic Key Players in India
10.3 India Opthalmic Therapeutic Market Size by Type
10.4 India Opthalmic Therapeutic Market Size by Application

11 Central & South America
11.1 Central & South America Opthalmic Therapeutic Market Size (2014-2019)
11.2 Opthalmic Therapeutic Key Players in Central & South America
11.3 Central & South America Opthalmic Therapeutic Market Size by Type
11.4 Central & South America Opthalmic Therapeutic Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Opthalmic Therapeutic Introduction
12.1.4 Pfizer Revenue in Opthalmic Therapeutic Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Opthalmic Therapeutic Introduction
12.2.4 Novartis Revenue in Opthalmic Therapeutic Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Opthalmic Therapeutic Introduction
12.3.4 GlaxoSmithKline Revenue in Opthalmic Therapeutic Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Alcon
12.4.1 Alcon Company Details
12.4.2 Company Description and Business Overview
12.4.3 Opthalmic Therapeutic Introduction
12.4.4 Alcon Revenue in Opthalmic Therapeutic Business (2014-2019)
12.4.5 Alcon Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Opthalmic Therapeutic Introduction
12.5.4 Merck Revenue in Opthalmic Therapeutic Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Opthalmic Therapeutic Introduction
12.6.4 Roche Revenue in Opthalmic Therapeutic Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Bayer
12.7.1 Bayer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Opthalmic Therapeutic Introduction
12.7.4 Bayer Revenue in Opthalmic Therapeutic Business (2014-2019)
12.7.5 Bayer Recent Development
12.8 Actavis
12.8.1 Actavis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Opthalmic Therapeutic Introduction
12.8.4 Actavis Revenue in Opthalmic Therapeutic Business (2014-2019)
12.8.5 Actavis Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Opthalmic Therapeutic Introduction
12.9.4 Boehringer Ingelheim Revenue in Opthalmic Therapeutic Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 R-Tech Ueno
12.10.1 R-Tech Ueno Company Details
12.10.2 Company Description and Business Overview
12.10.3 Opthalmic Therapeutic Introduction
12.10.4 R-Tech Ueno Revenue in Opthalmic Therapeutic Business (2014-2019)
12.10.5 R-Tech Ueno Recent Development
12.11 Valeant Pharmaceuticals
12.12 Regeneron Pharmaceuticals
12.13 Acadia Pharmaceuticals
12.14 Allergan
12.15 Falcon Pharmaceuticals
12.16 Otsuka Pharmaceutical
12.17 Senju Pharmaceutical
12.18 OPKO Health
12.19 Lexicon Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details